CRBU Q1 2023 Earnings — Caribou Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CRBUCaribou Biosciences, Inc.

$186M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+31.5% YoY

Gross Profit

-$22M-634.1% margin

Operating Income

-$31M-888.5% margin

Net Income

-$28M-800.8% margin

EPS (Diluted)

$-0.46

QoQ Revenue Growth

-5.1%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$30M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$347M

Total Liabilities

$69M

Stockholders' Equity

$278M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$3M	+31.5%
Gross Profit	-$22M	-$11M	-97.2%
Operating Income	-$31M	-$21M	-49.2%
Net Income	-$28M	-$19M	-46.9%

Geographic Segments

UNITED STATES

$3M97%

Non-US

$117,0003%